-
www.cpsi.ahrq.gov/research/findings/studies/index.html?page=484
January 01, 2024 - Regardless of age or sex, hypertension and hyperlipidemia was the most common dyad among adults treated
-
healthcare411.ahrq.gov/research/findings/studies/index.html?page=484
January 01, 2024 - Regardless of age or sex, hypertension and hyperlipidemia was the most common dyad among adults treated
-
cahps.ahrq.gov/research/findings/studies/index.html?page=484
January 01, 2024 - Regardless of age or sex, hypertension and hyperlipidemia was the most common dyad among adults treated
-
monahrq.ahrq.gov/research/findings/studies/index.html?page=484
January 01, 2024 - Regardless of age or sex, hypertension and hyperlipidemia was the most common dyad among adults treated
-
talkingquality.ahrq.gov/research/findings/studies/index.html?page=484
January 01, 2024 - Regardless of age or sex, hypertension and hyperlipidemia was the most common dyad among adults treated
-
patientregistry.ahrq.gov/research/findings/studies/index.html?page=484
January 01, 2024 - Regardless of age or sex, hypertension and hyperlipidemia was the most common dyad among adults treated
-
ahrqpubs.ahrq.gov/research/findings/studies/index.html?page=484
January 01, 2024 - Regardless of age or sex, hypertension and hyperlipidemia was the most common dyad among adults treated
-
teamstepps.ahrq.gov/research/findings/studies/index.html?page=484
January 01, 2024 - Regardless of age or sex, hypertension and hyperlipidemia was the most common dyad among adults treated
-
ce.effectivehealthcare.ahrq.gov/research/findings/final-reports/stpra/stpraapa2.html
April 01, 2018 - A history of cancer, hypertension, or thyroid problems were all associated with higher but statistically
-
www.ahrq.gov/research/findings/studies/index.html?page=33
January 01, 2024 - diagnosis and diagnosis of long COVID averaged 250 days; leading risk factors for long COVID included hypertension
-
www.ahrq.gov/research/findings/studies/index.html?page=43
January 01, 2024 - conditions, particularly heart disease, chronic kidney disease, chronic lung disease, diabetes, cancer, and hypertension
-
www.ahrq.gov/research/findings/studies/index.html?page=20
January 01, 2024 - arising from "buy or build" decisions in developing two digital health interventions aimed at improving hypertension
-
www.ahrq.gov/research/findings/studies/index.html?page=21
January 01, 2024 - age, 73.1 years, 56.1% male, 67.2% non-Hispanic White, median CHA2DS2-VASc [congestive heart failure, hypertension
-
www.ahrq.gov/research/findings/studies/index.html?page=59
January 01, 2024 - however, mixed findings were observed regarding the risk for post-donation chronic kidney disease and hypertension
-
effectivehealthcare.ahrq.gov/products/copd/protocol
October 10, 2018 - Comorbidities (tobacco abuse, pulmonary hypertension, congestive heart failure, morbid obesity, gastroesophageal
-
effectivehealthcare.ahrq.gov/sites/default/files/whitepaper4-bossuyt02262010-2.pdf
January 01, 2009 - illness cognitions have been shown to affect adherence behavior
among patients with HIV, diabetes, hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-testing-evaluation_research.pdf
January 01, 2009 - illness cognitions have been shown to affect adherence behavior
among patients with HIV, diabetes, hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2020.pdf
January 01, 2020 - Oral glucocorticoids and incident treatment of diabetes mellitus, hypertension, and venous
thromboembolism
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/whitepaper4-bossuyt02262010-2.pdf
January 01, 2009 - illness cognitions have been shown to affect adherence behavior
among patients with HIV, diabetes, hypertension
-
digital.ahrq.gov/sites/default/files/docs/citation/r18hs021162-mctigue-final-report-2018.pdf
January 01, 2018 - Similar results were
observed when the models were adjusted for sex,
clinic type, as hypertension and